about
Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an AntihistamineA Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1)The Effects of Antihistamines on Pre-Pulse InhibitionA Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistaminesA Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- AntihistaminesAnti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical ResearchEfficacy and Cost Analysis of Steroid Spray in Treatment of Otitis Media With EffusionA Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic UrticariaAntihistamines in Eosinophilic Esophagitis
P4844
Q2240116-88AC2B04-122D-4CF0-9AAC-0DFE675A9249Q27255766-7CD4B851-04FF-4F11-A258-48E5AC247320Q342745-CE110570-F204-42BB-AA2E-F978B949A912Q415122-C3CBBA66-2E60-443D-8CDA-CB8AAE4B6332Q417830-D87995E8-3F81-469E-822A-B979DEB2A333Q417909-C23348F2-5704-4E92-BD67-6A64B82FEF43Q418060-F0551F9C-3106-4A8B-A9DA-28427E3CE66FQ419820-E151C066-06D8-47B1-893B-EC1A49585FBDQ421091-7ADD4451-CF1C-4FAB-82AB-13FB816F9A5CQ423075-C2F57F2D-1B73-4B24-9146-858F1473531DQ423437-55F5FD7C-219D-4BF1-A353-7489F761D001Q424049-C71F63C9-2E26-4255-801F-A2D94EEF1783
P2868
Q61920787-82D38FAC-CFF9-4F91-B6A9-1D30DD643CD4Q61980956-A3427DFD-2163-411E-B913-6B692B4204D7Q63320031-8C1E8384-BE66-4E7A-B45F-77256BD113CFQ63339554-3894FEE9-5B35-4642-8CB3-75C801CAFB61Q63572657-2F508EBD-6077-4165-ADEF-5021D64552BBQ63575806-6F082C6E-A855-4D63-BE06-2F8FCB70E175Q63584856-39395950-0B04-4722-9A55-4FEC6298B29CQ63599527-4D0D0C46-0EA9-4585-860E-C767CBD1567EQ63613231-992970A3-EAF8-4737-95D6-AB8DA873897EQ86286476-8A88C21F-BB45-411D-AC4B-697CEB57CDB6
P4844
description
A class of non-sedating drugs ...... roup of compounds with differi
@en
name
Histamine H1 Antagonists, Non-Sedating
@en
antagonisti H1 histaminového receptoru, nesedativní
@cs
histamin-H1-antagonist, ikkje-sederande
@nn
type
label
Histamine H1 Antagonists, Non-Sedating
@en
antagonisti H1 histaminového receptoru, nesedativní
@cs
histamin-H1-antagonist, ikkje-sederande
@nn
altLabel
H1 Antihistamines, Non-Sedating
@en
H1 antihistaminika
@cs
Second Generation Antihistamines
@en
Second Generation H1 Antagonists
@en
antihistaminika 2. generace
@cs
antihistaminika druhé generace
@cs
histamin-H1-antagonistar, ikkje-sederande
@nn
ikkje-sederande histamin-H1-antagonist
@nn
ikkje-sederande histamin-H1-antagonistar
@nn
prefLabel
Histamine H1 Antagonists, Non-Sedating
@en
antagonisti H1 histaminového receptoru, nesedativní
@cs
histamin-H1-antagonist, ikkje-sederande
@nn
P486
P279
P486
P672
D27.505.519.625.375.425.400.500
D27.505.696.577.375.425.400.500